Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 586,395 | 618,696 | 938,944 | 631,908 | 1,087,720 |
| Marketable Securities | 21,900 | 18,800 | 16,100 | 13,200 | 12,100 |
| Receivables | 27,511 | 29,316 | 28,901 | 27,743 | 23,785 |
| Other current assets | 790,005 | 861,279 | 865,592 | 847,390 | 719,638 |
| TOTAL | $1,425,811 | $1,528,091 | $1,849,537 | $1,520,241 | $1,843,243 |
| Non-Current Assets | |||||
| PPE Net | 16,542,350 | 16,208,480 | 15,763,670 | 15,134,290 | 15,032,010 |
| Investments And Advances | 845,767 | 880,280 | 722,850 | 658,343 | 696,291 |
| Intangibles | 924,634 | 924,634 | 924,634 | 924,634 | 0 |
| Other Non-Current Assets | 76,859 | 79,296 | 86,586 | 85,493 | 36,709 |
| TOTAL | $18,389,610 | $18,092,690 | $17,497,740 | $16,802,760 | $15,765,010 |
| Total Assets | $19,815,410 | $19,620,780 | $19,347,280 | $18,323,000 | $17,608,260 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 380,000 | 380,000 | 380,000 | 999,436 | 998,605 |
| Accounts payable and accrued liabilities | 112,900 | 92,229 | 118,637 | 118,406 | 146,426 |
| Accrued Expenses | 25,302 | 110,818 | 29,044 | 85,609 | 19,221 |
| Other current liabilities | 17,480 | 53,164 | 3,121 | 3,075 | 18,600 |
| TOTAL | $535,682 | $636,211 | $530,802 | $1,206,526 | $1,182,852 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,576,443 | 8,570,917 | 8,565,735 | 7,003,063 | 6,618,847 |
| Other Non-Current Liabilities | 592,891 | 557,005 | 473,888 | 550,012 | -177,184 |
| TOTAL | $9,342,900 | $9,269,630 | $9,195,617 | $7,613,534 | $6,636,747 |
| Total Liabilities | $9,878,582 | $9,905,841 | $9,726,419 | $8,820,060 | $7,819,599 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 575,832 | 576,857 | 577,238 | 583,174 | 562,240 |
| Common Shares | 108 | 106 | 107 | 107 | 106 |
| Retained earnings | 2,507,091 | 2,356,318 | 2,304,314 | 2,222,750 | 2,480,664 |
| Other shareholders' equity | 3,048,578 | 3,238,427 | 3,206,902 | 3,155,418 | 3,100,356 |
| TOTAL | $9,936,833 | $9,714,939 | $9,620,861 | $9,502,940 | $9,788,657 |
| Total Liabilities And Equity | $19,815,415 | $19,620,780 | $19,347,280 | $18,323,000 | $17,608,256 |